Cytogel Pharma, LLC
Filing history at a glance
The reported offering amount was $1,000,000 in the Dec 23, 2025 filing and $16,000,000 in the Mar 26, 2026 filing. The two records may concern different offerings. Amendments account for 2 of the 3 filings stored from Dec 23, 2025 to Mar 26, 2026.
through Mar 26, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Dec 23, 2025 · D/A | Mar 26, 2026 · D/A | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $1,000,000 | $16,000,000 | $15,000,000 |
| Reported amount sold | $250,000 | $0 | $-250,000 |
| Reported investor count | — | — | — |
| Reported minimum investment | $50,000 | $50,000 | $0 |
Earlier SEC source: 0001213900-25-125022 · Later SEC source: 0001213900-26-034790
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot
- Reported offering amount
- $16,000,000
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $0
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Filings by year
- 20252 filings
- 20261 filing
Submission counts, including amendments; not dollars raised or distinct funding rounds.
Same reported sales compensation recipient
Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.
- Hickory Lending Fund VIII LLC · CIK 2060210
- S3 Small Balance RE Credit A Foreign LLC · CIK 2074318
Shared EDGAR submitting account
These filings share an external submitting CIK in their accession numbers. The account may belong to a filing agent. How EDGAR assigns accession numbers.
- 1st American Nuclear Co. · CIK 2074867
- 1TECH Intelligence, Inc. · CIK 2134898
- 3D Group Holdings LLC · CIK 2154989
- ABVC BIOPHARMA, INC. · CIK 1173313
- ACTELIS NETWORKS INC · CIK 1141284
Form D filings (3)
-
0001213900-26-034790D/A · Mar 26, 2026 · PharmaceuticalsOffering: $16,000,000Sold: $0
Compared with 0001213900-25-125022:
- Reported offering amount: $1,000,000 → $16,000,000
- Reported amount sold: $250,000 → $0
-
0001213900-25-125022D/A · Dec 23, 2025 · PharmaceuticalsOffering: $1,000,000Sold: $250,000
Same filing date; order cannot be established.
-
0001213900-25-124742D · Dec 23, 2025 · PharmaceuticalsOffering: $16,000,000Sold: $0